Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oscillating viscometer--evaluation of a new bedside test.

M Mark1, K Häusler, J Dual

  • 1Internal Medicine, Kantonsspital, CH-7000 Chur, Switzerland.

Biorheology
|May 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diode laser pumps for future inertial fusion energy systems: status and perspectives: publisher's note.

Optics express·2026
Same author

Diode laser pumps for future inertial fusion energy systems: status and perspectives.

Optics express·2025
Same author

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.

ESMO open·2025
Same author

First Constraints on General Neutrino Interactions Based on KATRIN Data.

Physical review letters·2025
Same author

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

ESMO open·2023
Same author

New Constraint on the Local Relic Neutrino Background Overdensity with the First KATRIN Data Runs.

Physical review letters·2022

A novel oscillating viscometer enables bedside blood viscosity measurements. This device offers new insights into blood biorheology, particularly the erythrocyte-poor boundary layer, and is practical for clinical use.

Area of Science:

  • Biomedical Engineering
  • Hemodynamics
  • Rheology

Background:

  • Blood viscosity is a critical parameter in cardiovascular health.
  • Conventional viscometers are not suitable for rapid bedside measurements.
  • Understanding blood's viscoelastic properties is essential for diagnosing and managing various conditions.

Purpose of the Study:

  • To develop and validate an oscillating viscometer for bedside blood viscosity measurements.
  • To compare the performance of oscillating viscometry with a conventional Couette viscometer.
  • To investigate the influence of hematocrit, fibrinogen, and erythrocyte aggregation on blood viscosity measurements.

Main Methods:

  • Development of an oscillating resonator probe integrated into a disposable blood collection tube.

Related Experiment Videos

  • In vitro testing with blood samples of varying hematocrit, fibrinogen, and contrast medium concentrations.
  • Comparison of oscillating viscometry results with a conventional Couette viscometer.
  • Bedside testing in patients with coronary heart disease and healthy controls.
  • Main Results:

    • Oscillating viscometry showed good sensitivity to hematocrit changes, correlating well with the Couette method (r=0.96).
    • Blood exhibited viscoelastic behavior, with viscosity varying based on resonator frequency and shear wave penetration depth.
    • Erythrocyte aggregation influenced measurements, decreasing viscosity at high frequencies (shallow penetration) and increasing it at low frequencies (deep penetration).
    • Bedside tests demonstrated the device's practicability and revealed lower oscillating viscosity in coronary heart disease patients.

    Conclusions:

    • Oscillating viscometry is a practical and sensitive bedside tool for blood viscosity assessment.
    • The method provides novel information on the biorheology of the erythrocyte-poor boundary layer.
    • This technique holds potential for improved diagnosis and monitoring of cardiovascular conditions.